Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer.

Pharmaceuticals (Basel) · 2025 · PMC12196445 · PMID 40573326

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

closer to significancep = 0.071so close (0.05 < p ≤ 0.1)

Regarding mortality, postmenopausal patients (60.0%) are closer to significance ( p = 0.071) than age, sex, and BMI-matched patients (39.6%).

also in 43 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.